Related content

Microbial genomics – new targets, new drugs

By Schmid Molly B  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 465-475

Informa Healthcare

Access to resources Recommend Favorite

Statins and their potential targets in multiple sclerosis therapy

By Stüve Olaf   Prod’homme Thomas   Slavin Anthony   Youssef Sawsan   Dunn Shannon   Steinman Lawrence   Zamvil Scott S  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 613-622

Informa Healthcare

Access to resources Recommend Favorite

Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 22, 2014-11 ,pp. : 2590-2599

Bentham Science Publishers

Access to resources Recommend Favorite

New therapeutic targets for amyotrophic lateral sclerosis

By Kuzma-Kozakiewicz Magdalena   Kwiecinski Hubert  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 127-143

Informa Healthcare

Access to resources Recommend Favorite

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 279-290

Bentham Science Publishers

Access to resources Recommend Favorite